If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. If you rely on the lifesaving ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged ...

Lindsay Green learned that her 2-year-old son, Everett, had a peanut allergy when he was around 10 months old, leading her to learn more about how to protect her baby. Now, she has taken this concern ...

Phillips-Medisize, in collaboration with its customer, Ascendis Pharma, was recently recognized with a third industry award for the Skytrofa Auto-Injector. The Red Dot Award recognizes the drug ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

DUBLIN--(BUSINESS WIRE)--The "Auto Injector Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030" report has been added to ResearchAndMarkets.com's offering. The report on ...

EpiPen is a first-line, emergency treatment for severe allergic reactions. Benadryl is used for milder allergic reactions. The decision of when to use one or the other depends on the specific symptoms ...

The FDA approved the first nalmefene hydrochloride auto-injector (Zurnai) for use as an emergency treatment for opioid overdose in adults and children 12 years of age and older, the agency announced ...